Geriatric Gastroenterology 2020
DOI: 10.1007/978-3-319-90761-1_52-1
|View full text |Cite
|
Sign up to set email alerts
|

Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 60 publications
0
1
0
Order By: Relevance
“…An effective drug that can prevent and treat NAFLD has not been developed. Most patients with NAFLD may have no obvious clinical symptoms ( Krawitz and Pyrsopoulos, 2020 ). Early control and intervention can effectively reverse disease progression.…”
Section: Introductionmentioning
confidence: 99%
“…An effective drug that can prevent and treat NAFLD has not been developed. Most patients with NAFLD may have no obvious clinical symptoms ( Krawitz and Pyrsopoulos, 2020 ). Early control and intervention can effectively reverse disease progression.…”
Section: Introductionmentioning
confidence: 99%